Literature DB >> 6172627

In vitro reversal of depressed T-lymphocyte function in the peripheral blood of brain tumor patients.

G W Wood, R A Morantz.   

Abstract

Peripheral blood mononuclear cells from some brain tumor patients exhibited depressed T-lymphocyte responses to the polyclonal mitogen phytohemagglutinin (PHA). These responses, initially depressed, were restored to near normal by a 24-hour preculture in growth medium. The effect of preculture was mimicked by mild trypsinization before addition of PHA. In addition, cells treated with deaggregated antihuman IgG resulted in greatly reduced responses to mitogen by mononuclear cells from all brain tumor patients. Anti-IgG had no effect if cells were precultured for 24 hours. The results suggest that, in brain tumor patients, depressed immune function associated with tumor progression was caused by suppressor cells which were activated by humoral factors that express IgG antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6172627

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

Authors:  F P Holladay; T Heitz-Turner; W L Bayer; G W Wood
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

2.  Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis.

Authors:  C R Rinaldo; M Ho; W H Hamoudi; X E Gui; R L DeBiasio
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

Review 3.  Medulloblasoma: challenges for effective immunotherapy.

Authors:  Adam M Sonabend; Alfred T Ogden; Lisa M Maier; David E Anderson; Peter Canoll; Jeffrey N Bruce; Richard C E Anderson
Journal:  J Neurooncol       Date:  2011-12-16       Impact factor: 4.130

4.  Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.

Authors:  L H Elliott; W H Brooks; T L Roszman
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells.

Authors:  G W Wood; R A Morantz
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

Review 6.  Cellular immunotherapy for pediatric solid tumors.

Authors:  Meenakshi Hegde; Alexander J Moll; Tiara T Byrd; Chrystal U Louis; Nabil Ahmed
Journal:  Cytotherapy       Date:  2014-07-28       Impact factor: 5.414

Review 7.  Immunotherapy for Medulloblastoma: Current Perspectives.

Authors:  Tanvir F Kabir; Charles A Kunos; John L Villano; Aman Chauhan
Journal:  Immunotargets Ther       Date:  2020-04-20

8.  Inhibition of tumor necrosis factor-alpha and -beta secretion by lymphokine activated killer cells by transforming growth factor-beta.

Authors:  H Naganuma; A Sasaki; E Satoh; M Nagasaka; S Nakano; S Isoe; K Tasaka; H Nukui
Journal:  Jpn J Cancer Res       Date:  1994-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.